OptMyCare, a clinically engineered AI platform in healthcare & risk management, announced today that it raised $3 million in Series A financing from a robust group of investors led by LiveOak Ventures of Austin, Texas. This infusion of additional capital will enable OptMyCare™ to accelerate its customer acquisition plans, continuously refine its technology, onboard key management personnel, and add experienced healthcare & technology leaders. Total investment to date is $4.5 million.

Founded in 2019 by Dr. Antony E. Pfaffle, MD, and Dr. Saravanan Balamuthusamy, MD, MPH, FASN, FASDIN, OptMyCare™ brings a uniquely clinical perspective to the engineering of health risk solutions. Dr. Pfaffle has twenty years of experience in stop-loss and risk management consulting and has founded or co-founded multiple healthcare companies. Dr. Balamuthusamy cofounded a large multispecialty physician group in North Texas and brings in two decades of academic clinical experience in developing a comprehensive health risk management solution. Working with a team of healthcare, tech, and insurance experts, Dr. Pfaffle and Dr. Balamuthusamy aim to revolutionize the field of risk management, utilizing technologically unique precision analytics to change the way that companies navigate risk.